Oscar Health Inc
$ 14.91
-0.13%
26 Dec - close price
- Market Cap 4,293,442,000 USD
- Current Price $ 14.91
- High / Low $ 14.96 / 14.73
- Stock P/E N/A
- Book Value 3.92
- EPS -0.90
- Next Earning Report 2026-02-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -0.22 %
- 52 Week High 23.80
- 52 Week Low 11.20
About
Oscar Health, Inc. is a cutting-edge health insurance provider based in New York, recognized for its innovative, technology-driven solutions for individuals, families, and businesses across the United States. The company utilizes a proprietary platform to enhance member engagement, offering personalized care management and streamlined access to healthcare services, aimed at improving health outcomes while controlling costs. As a leader at the intersection of technology and health insurance, Oscar Health is strategically positioned to transform industry dynamics, appealing to a diverse range of health-conscious consumers and solidifying its role as a significant player in the evolving healthcare market.
Analyst Target Price
$14.67
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-06 | 2025-05-07 | 2025-02-04 | 2024-11-07 | 2024-08-07 | 2024-05-07 | 2024-02-07 | 2023-11-07 | 2023-08-08 | 2023-05-09 | 2023-02-09 |
| Reported EPS | -0.53 | -0.89 | 0.92 | -0.62 | -0.22 | 0.2 | 0.62 | -0.66 | -0.29 | -0.07 | -0.18 | -1.05 |
| Estimated EPS | -0.5 | -0.89 | 0.81 | -0.58 | -0.18 | 0.16 | 0.27 | -0.7 | -0.47 | -0.16 | -0.09 | -1.19 |
| Surprise | -0.03 | 0 | 0.11 | -0.04 | -0.04 | 0.04 | 0.35 | 0.04 | 0.18 | 0.09 | -0.09 | 0.14 |
| Surprise Percentage | -6% | 0% | 13.5802% | -6.8966% | -22.2222% | 25% | 129.6296% | 5.7143% | 38.2979% | 56.25% | -100% | 11.7647% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-03 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.84 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OSCR
2025-12-24 11:09:54
Oscar Health (OSCR) is facing renewed scrutiny due to intensifying regulatory and competitive pressures, particularly in the Georgia market, which could impact its profitability. Despite a recent recovery in share price and strong longer-term shareholder returns, the stock's current valuation, slightly above Wall Street targets, raises questions about whether it is overvalued amidst these risks. Analysts have a consensus price target of $11.143, with a fair value narrative suggesting slight overvaluation, while market multiples indicate potential value.
2025-12-15 14:09:22
Oscar Health (OSCR) has gained attention due to new analyst coverage from Stephens and Co. and a partnership with Broward Health. While a narrative fair value suggests the stock is 15.7% overvalued at $14.38, its price-to-sales ratio indicates it might be undervalued compared to peers, implying market sentiment is overly cautious. The article suggests investors consider both the promising growth forecasts and the current market multiples when evaluating OSCR.
2025-12-08 15:09:07
Oscar Health, despite facing higher-than-expected claims losses earlier in the year, saw a 23% revenue increase in Q3 2025 and has growing membership exceeding 2 million, supported by its tech-driven platform. The company's 2025 guidance projects significant revenue growth and a reduced loss from operations, although analyst views on its fair value vary widely. Investors are closely monitoring medical loss ratio normalization and execution on pricing to gauge the company's long-term profitability.
2025-12-06 13:08:47
Oscar Health (OSCR) has seen a surge in investor confidence following bullish options activity and an analyst upgrade, despite still reporting losses. The company's stock has shown strong year-to-date and three-year returns, sparking debate on whether its current valuation is justified. While some metrics suggest Oscar Health is overvalued, others like its low price-to-sales ratio indicate potential undervaluation.
2025-12-01 04:43:14
Oscar Health (OSCR) saw a significant stock boost after analysts at Piper Sandler upgraded its rating, citing the company's resilience in gaining market share and improving profitability despite potential ACA subsidy uncertainties. The prospect of extended Affordable Care Act subsidies is highlighted as a key factor that could provide stability and consistent membership for Oscar Health, influencing its investment narrative positively. While Oscar Health shows growth in revenue and membership, profitability remains a challenge due to high operating costs.
2025-12-01 04:43:14
Oscar Health (OSCR) shares surged after news of a potential two-year extension of Obamacare subsidies and expanded eligibility, sparking investor optimism despite the company's valuation being deemed "Overvalued" by analysts at $12.88. While the stock's one-year return is modest, its three-year return shows significant growth. The article also notes Oscar Health's low price-to-sales ratio compared to industry peers, suggesting potential for upside if market sentiment shifts.
